Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep:29 Suppl 4:iv1-8.
doi: 10.1093/ndt/gfu030.

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry

Affiliations

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry

Elke Wühl et al. Nephrol Dial Transplant. 2014 Sep.

Abstract

Background: In recent years, increased efforts have been undertaken to address the needs of patients with rare diseases by international initiatives and consortia devoted to rare disease research and management. However, information on the overall prevalence of rare diseases within the end-stage renal disease (ESRD) population is limited. The aims of this study were (i) to identify those rare diseases within the ERA-EDTA Registry for which renal replacement therapy (RRT) is being provided and (ii) to determine the prevalence and incidence of RRT for ESRD due to rare diseases, both overall and separately for children and adults.

Methods: The Orphanet classification of rare disease was searched for rare diseases potentially causing ESRD, and these diagnosis codes were mapped to the corresponding ERA-EDTA primary renal disease codes. Thirty-one diagnoses were defined as rare diseases causing ESRD.

Results: From 1 January 2007 to 31 December 2011, 7194 patients started RRT for a rare disease (10.6% children). While some diseases were exclusively found in adults (e.g. Fabry disease), primary oxalosis, cystinosis, congenital anomalies of the kidney and urinary tract (CAKUT) and medullary cystic kidney disease affected young patients in up to 46%. On 31 December 2011, 20 595 patients (12.4% of the total RRT population) were on RRT for ESRD caused by a rare disease. The point prevalence was 32.5 per million age-related population in children and 152.0 in adults. Only 5.8% of these patients were younger than 20 years; however, 57.7% of all children on RRT had a rare disease, compared with only 11.9% in adults. CAKUT and focal segmental glomerulosclerosis were the most prevalent rare disease entities among patients on RRT.

Conclusions: More than half of all children and one of nine adults on RRT in the ERA-EDTA Registry suffer from kidney failure due to a rare disease, potentially with a large number of additional undiagnosed or miscoded cases. Comprehensive diagnostic assessment and the application of accurate disease classification systems are essential for improving the identification and management of patients with rare kidney diseases.

Keywords: incidence; orphan disease; prevalence; rare disease; renal replacement therapy.

PubMed Disclaimer

Similar articles

Cited by

  • Excellent long-term outcome of renal transplantation in cystinosis patients.
    Cohen C, Charbit M, Chadefaux-Vekemans B, Giral M, Garrigue V, Kessler M, Antoine C, Snanoudj R, Niaudet P, Kreis H, Legendre C, Servais A. Cohen C, et al. Orphanet J Rare Dis. 2015 Jul 25;10:90. doi: 10.1186/s13023-015-0307-9. Orphanet J Rare Dis. 2015. PMID: 26208493 Free PMC article.
  • Risks and benefits of ChatGPT in informing patients and families with rare kidney diseases: an explorative assessment by the European Rare Kidney Disease Reference Network (ERKNet).
    van Eerde AM, Teixeira A, Galletti F, Maternik M, Capone V, Westland R, Mulder J, Halbritter J, Osterholt T, Neukel V, Weber LT, Liebau MC, Schaefer F, Kohl S. van Eerde AM, et al. Pediatr Nephrol. 2025 Sep;40(9):2899-2905. doi: 10.1007/s00467-025-06746-w. Epub 2025 Apr 16. Pediatr Nephrol. 2025. PMID: 40237816 Free PMC article.
  • Diagnostic Utility of Exome Sequencing for Kidney Disease.
    Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J, Krithivasan P, Lam WY, Mitrotti A, Piva S, Kil BH, Chatterjee D, Reingold R, Bradbury D, DiVecchia M, Snyder H, Mu X, Mehl K, Balderes O, Fasel DA, Weng C, Radhakrishnan J, Canetta P, Appel GB, Bomback AS, Ahn W, Uy NS, Alam S, Cohen DJ, Crew RJ, Dube GK, Rao MK, Kamalakaran S, Copeland B, Ren Z, Bridgers J, Malone CD, Mebane CM, Dagaonkar N, Fellström BC, Haefliger C, Mohan S, Sanna-Cherchi S, Kiryluk K, Fleckner J, March R, Platt A, Goldstein DB, Gharavi AG. Groopman EE, et al. N Engl J Med. 2019 Jan 10;380(2):142-151. doi: 10.1056/NEJMoa1806891. Epub 2018 Dec 26. N Engl J Med. 2019. PMID: 30586318 Free PMC article.
  • Rare Kidney Diseases: Children Being Left Out in the Cold.
    Iyengar A, Lanewala AA, Shirol PB, Pais P. Iyengar A, et al. Clin J Am Soc Nephrol. 2023 Nov 10;19(4):528-30. doi: 10.2215/CJN.0000000000000374. Online ahead of print. Clin J Am Soc Nephrol. 2023. PMID: 37948090 Free PMC article. No abstract available.
  • The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results.
    Bassanese G, Wlodkowski T, Servais A, Heidet L, Roccatello D, Emma F, Levtchenko E, Ariceta G, Bacchetta J, Capasso G, Jankauskiene A, Miglinas M, Ferraro PM, Montini G, Oh J, Decramer S, Levart TK, Wetzels J, Cornelissen E, Devuyst O, Zurowska A, Pape L, Buescher A, Haffner D, Marcun Varda N, Ghiggeri GM, Remuzzi G, Konrad M, Longo G, Bockenhauer D, Awan A, Andersone I, Groothoff JW, Schaefer F. Bassanese G, et al. Orphanet J Rare Dis. 2021 Jun 2;16(1):251. doi: 10.1186/s13023-021-01872-8. Orphanet J Rare Dis. 2021. PMID: 34078418 Free PMC article.

Publication types

MeSH terms